Omega-3 Topical Treatment for Eczema

(COS-PBP-03 Trial)

AL
SF
Overseen BySamuel Fortin, PhD, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: SCF Pharma
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This exploratory study aims to investigate the prebiotic potential of daily application of an omega-3 serum and cream to skin affected by eczema. The study will also collect data on any potential adverse effects of the products. Ten subjects will be enrolled in the study and will receive the same treatment for fourteen days. Their baseline condition before treatment will serve as a control for the effects observed after treatment on the targeted eczema area. A second area of eczema treated with the patient's usual skincare routine will also serve as a control.

Who Is on the Research Team?

SF

Samuel Fortin, PhD

Principal Investigator

SCF Pharma

Are You a Good Fit for This Trial?

This trial is for adults (18+) diagnosed with eczema who haven't used steroid creams in the past 14 days. Participants must be able to understand and follow study instructions, give informed consent, and be available for the full two-week study.

Inclusion Criteria

I have eczema and haven't used corticosteroids in the past 14 days.
I am able and willing to participate in the full study and have signed the consent form.
I am at least 18 years old.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 week
1 visit (in-person)

Treatment

Participants apply the omega-3 serum and cream daily to the targeted eczema area for 14 days

2 weeks
3 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

2 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Omega-3 Monoglycerides Based Serum and Cream

Trial Overview

The study tests a daily omega-3 monoglyceride serum and cream applied to eczema-affected skin for 14 days. Each participant's usual skincare routine on another area serves as a comparison.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: MagOX topic treatmentExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

SCF Pharma

Lead Sponsor

Trials
7
Recruited
340+